肝硬化肌少症的发病机制与诊疗现状的研究进展  

Current Research Progress of Pathogenesis, Diagnosis and Treatment of Sarcopenia in Liver Cirrhosis

作　　者：蔡剑平 杨金煜[2] 

机构地区：[1]青海大学研究生院普通外科,青海 西宁 [2]青海省人民医院普通外科(三病区),青海 西宁

出　　处：《临床医学进展》2023年第7期11664-11671,共8页Advances in Clinical Medicine

摘　　要：随着肝硬化患者的营养状态受到越来越多国内外学者的重视,而肌肉减少症是肝硬化患者营养不良的主要临床表现之一,其发病机制和诊疗现状引起了人们的广泛关注。肌肉减少症是肝硬化患者失代偿期常见的并发症之一,是影响肝硬化患者疾病进展和预后的独立危险因素,目前发病率高达40%~70%。本文将通过查阅有关肝硬化肌肉减少症发病特点、发病机制、诊断方法和治疗干预等方面的最新文献对肌少症的进展作一综述,以期为肝硬化肌少症提供研究和治疗的思路。With more and more attention being paid to the nutritional status of patients with cirrhosis, sarco-penia is one of the main clinical manifestations of malnutrition in patients with cirrhosis, and its pathogenesis and current diagnosis and treatment have attracted extensive attention. As one of the common complications of decompensation in patients with cirrhosis, sarcopenia is an independent risk factor affecting disease progression and prognosis in patients with cirrhosis, with a current in-cidence of 40%~70%. This paper reviews the progress of sarcopenia by referring to the latest liter-ature on the pathogenesis, pathogenesis, diagnosis and therapeutic intervention of sarcopenia of cirrhosis, in order to provide ideas for the research and treatment of sarcopenia of cir- rhosis.

关 键 词：肝硬化 肌少症 营养不良 

分 类 号：R57[医药卫生—消化系统]